Bosh sahifaORCHPHARMA • NSE
add
Orchid Pharma Ltd
Yopilish kursi
1 336,40 ₹
Kunlik diapazon
1 335,00 ₹ - 1 420,00 ₹
Yillik diapazon
713,00 ₹ - 1 997,40 ₹
Bozor kapitalizatsiyasi
71,49 mlrd INR
Oʻrtacha hajm
89,89 ming
Narx/foyda
58,83
Dividend daromadliligi
-
Asosiy maydon
NSE
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,23 mlrd | 12,05% |
Joriy xarajat | 698,25 mln | 14,56% |
Sof foyda | 272,36 mln | 37,53% |
Sof foyda marjasi | 12,23 | 22,79% |
Har bir ulushga tushum | 5,37 | — |
EBITDA | 302,47 mln | 30,11% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,44 mlrd | 384,25% |
Jami aktivlari | 16,35 mlrd | 9,59% |
Jami passivlari | 4,11 mlrd | 6,94% |
Umumiy kapital | 12,24 mlrd | — |
Tarqatilgan aksiyalar | 50,72 mln | — |
Narxi/balansdagi bahosi | 5,54 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 4,03% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 272,36 mln | 37,53% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Tashkil etilgan
1992
Sayt
Xodimlar soni
871
